Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs2997989 | chr13:114152265 | T/C | 4.5E-12 | 177 | 24.17 | 29.57 | 3.32 | KM Plot |
PCPG | rs2997997 | chr13:114163702 | T/C | 6.32E-12 | 176 | 24.1 | 29.57 | 3.32 | KM Plot |
PCPG | rs3008218 | chr1:26375577 | A/G | 1.89E-5 | 178 | 25.17 | 25.63 | 25.53 | KM Plot |
PCPG | rs3021514 | chr8:11302044 | G/T | 8.89E-6 | 177 | 25.53 | 21.1 | 14.15 | KM Plot |
PCPG | rs3049877 | chr3:80692353 | C/CAT | 0.000182 | 176 | 19.53 | 24.5 | 27.2 | KM Plot |
PCPG | rs3066970 | chr1:106638335 | TAA/T | 0.000289 | 171 | 25.28 | 25.9 | 3.17 | KM Plot |
PCPG | rs3079523 | chr2:107255079 | GAA/G | 0.000336 | 172 | 26.57 | 21.95 | 25.87 | KM Plot |
PCPG | rs3097417 | chr3:53088601 | C/G | 7.29E-6 | 174 | 11.78 | 19.72 | 25.77 | KM Plot |
PCPG | rs3103589 | chr5:171532333 | T/C | 3.37E-6 | 175 | 25.87 | 22.3 | 17.12 | KM Plot |
PCPG | rs3103590 | chr5:171532277 | C/T | 4.55E-5 | 178 | 25.87 | 19.2 | 17.12 | KM Plot |
PCPG | rs3103591 | chr5:171532229 | G/A | 0.000114 | 177 | 25.87 | 22.3 | 17.12 | KM Plot |
PCPG | rs3103592 | chr5:171531992 | A/G | 0.000114 | 177 | 25.87 | 22.3 | 17.12 | KM Plot |
PCPG | rs3103594 | chr5:171531899 | G/A | 0.000114 | 177 | 25.87 | 22.3 | 17.12 | KM Plot |
PCPG | rs3111484 | chr5:171532397 | C/T | 4.55E-5 | 178 | 25.87 | 19.2 | 17.12 | KM Plot |
PCPG | rs3111485 | chr5:171532373 | A/G | 4.55E-5 | 178 | 17.12 | 19.2 | 25.87 | KM Plot |